Axsome Therapeutics (AXSM) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 24.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.18% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.92% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -26.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.65% |
| Dec 31, 2025 | -3.77% |
| Sep 30, 2025 | -11.42% |
| Jun 30, 2025 | -7.87% |
| Mar 31, 2025 | -4.80% |
| Dec 31, 2024 | -30.97% |
| Sep 30, 2024 | -29.66% |
| Jun 30, 2024 | -1.63% |
| Mar 31, 2024 | 15.50% |
| Dec 31, 2023 | 17.17% |
| Sep 30, 2023 | 54.87% |
| Jun 30, 2023 | 15.98% |
| Mar 31, 2023 | 52.51% |
| Dec 31, 2022 | 154.36% |
| Sep 30, 2022 | 99.11% |
| Jun 30, 2022 | 660.52% |
| Mar 31, 2022 | 520.25% |
| Dec 31, 2021 | 439.15% |
| Sep 30, 2021 | 692.28% |
| Jun 30, 2021 | 174.29% |
| Mar 31, 2021 | 115.30% |
| Dec 31, 2020 | 71.92% |
| Sep 30, 2020 | 15.02% |
| Jun 30, 2020 | -25.34% |
| Mar 31, 2020 | -14.54% |
| Dec 31, 2019 | -40.92% |
| Sep 30, 2019 | -46.04% |
| Jun 30, 2019 | -40.63% |
| Mar 31, 2019 | -42.87% |
| Dec 31, 2018 | -23.86% |
| Sep 30, 2018 | -19.29% |
| Jun 30, 2018 | -20.68% |
| Mar 31, 2018 | -24.39% |
| Dec 31, 2017 | -32.42% |
| Sep 30, 2017 | -24.02% |
| Jun 30, 2017 | 156.06% |
| Mar 31, 2017 | 271.21% |
| Dec 31, 2016 | 504.88% |